NCCN VERSION 2 2015

NCCN Guidelines Version 2.2015 Breast Cancer

NCCN Guidelines Index Breast Cancer Table of Contents Discussion

Oncol 2011;103:212-216. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21337549 .

57. Gilleard O, Goodman A, Cooper M, et al. The significance of the Van Nuys prognostic index in the management of ductal carcinoma in

situ. World J Surg Oncol 2008;6:61-61. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18564426 .

65. Goodwin A, Parker S, Ghersi D, Wilcken N. Post-operative radiotherapy for ductal carcinoma in situ of the breast--a systematic review of the randomised trials. Breast 2009;18:143-149. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19447038 . 66. Waddell BE, Stomper PC, DeFazio JL, et al. Postexcision mammography is indicated after resection of ductal carcinoma-in-situ of the breast. Ann Surg Oncol 2000;7:665-668. Available at: http://www.ncbi.nlm.nih.gov/pubmed/11034243 . 67. Julian TB, Land SR, Fourchotte V, et al. Is sentinel node biopsy necessary in conservatively treated DCIS? Ann Surg Oncol 2007;14:2202-2208. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17534687 . 68. Cody HS, Van Zee KJ. Point: sentinel lymph node biopsy is indicated for patients with DCIS. J Natl Compr Canc Netw 2003;1:199- 206. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19768878 . 69. Edge SB, Sheldon DG. Counterpoint: sentinel lymph node biopsy is not indicated for ductal carcinoma in situ. J Natl Compr Canc Netw 2003;1:207-212. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19768879 . 70. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23:7703-7720. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16157938 . 71. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 2005;97:1652-1662. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16288118 .

58. Silverstein MJ, Lagios MD, Craig PH, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer 1996;77:2267-2274. Available at: http://www.ncbi.nlm.nih.gov/pubmed/8635094 . 59. Silverstein MJ, Lagios MD, Groshen S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N 60. Hughes LL, Wang M, Page DL, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2009;27:5319-5324. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19826126 . 61. Wong P, Lambert C, Agnihotram RV, et al. Ductal carcinoma in situ- the influence of the radiotherapy boost on local control. Int J Radiat Oncol Biol Phys 2011. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21664063 . 62. MacDonald HR, Silverstein MJ, Mabry H, et al. Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins. Am J Surg 2005;190:521-525. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16164913 . 63. Dunne C, Burke JP, Morrow M, Kell MR. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol 2009;27:1615-1620. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19255332 . 64. Groot G, Rees H, Pahwa P, et al. Predicting local recurrence following breast-conserving therapy for early stage breast cancer: the significance of a narrow (

Version 2.2015, 03/11/15 © National Comprehensive Cancer Network, Inc. 2015, All rights reserved. The NCCN Guidelines® and this illustration may not be reproduced in any form without the express written permission of NCCN®. MS-71